Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Experimental Therapeutics
  • Published:

Characterization of cell death induced by vinflunine, the most recent Vinca alkaloid in clinical development

British Journal of Cancer volume 86, pages 143–150 (2002)Cite this article

Abstract

Vinflunine, the most recent Vinca alkaloid in clinical development, demonstrated superior antitumour activity to other Vincas in preclinical tumour models. This study aimed to define its molecular mechanisms of cell killing in both parental sensitive and vinflunine-resistant P388 leukaemia cells. Vinflunine treatment of these cells resulted in apoptosis characterized by DNA fragmentation and proteolytic cleavage of poly-(ADP-ribose) polymerase. Apoptosis-inducing concentrations of vinflunine caused c-Jun N-terminal kinase 1 stimulation, as well as caspases-3/7 activation. This activation of caspases and the induction of apoptosis could be inhibited by the caspase inhibitor acetyl-Asp-Glu-Val-Asp-aldehyde. Interestingly, the apoptosis signal triggered by vinflunine in these P388 cells was not mediated through Bcl-2 phosphorylation. In addition, when vinflunine resistance was developed in P388 cells, it was associated with resistance to vinflunine-induced apoptosis, as reflected by a loss of capacity to induce DNA fragmentation and PARP degradation, and characterized by increased levels of Bcl-2 and Bfl-1/A1. Therefore, these data indirectly implicate Bcl-2 and Bfl-1/A1 in vinflunine-induced cell death mechanisms.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Basu A, Haldar S (1998) Microtubule-damaging drugs triggered Bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of Bcl2 protein. Int J Oncol 13: 659–664

    CAS  PubMed  Google Scholar 

  • Bertrand R, Sarang M, Jenkin J, Kerrigan D, Pommier Y (1991) Differential induction of secondary fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res 51: 6280–6285

    CAS  PubMed  Google Scholar 

  • Brown JM, Wouters BG (1999) Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 59: 1391–1399

    CAS  PubMed  Google Scholar 

  • Cheng Q, Lee HH, Li Y, Parks TP, Cheng G (2000) Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-kappaB inhibition. Oncogene 19: 4936–4940

    Article  CAS  PubMed  Google Scholar 

  • Etiévant C, Barret J-M, Kruczynski A, Perrin D, Hill BT (1998) Vinflunine (20′,20′-difluoro-3′,4′-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro. Invest New Drugs 16: 3–17

    Article  PubMed  Google Scholar 

  • Fahy J, Duflos A, Ribet J-P, Jacquesy J-C, Berrier C, Jouannetaud M-P, Zunino F (1997) Vinca alkaloids in superacidic media: a method for creating a new family of antitumor derivatives. J Am Chem Soc 119: 8576–8577

    Article  CAS  Google Scholar 

  • Fujita N, Tsuruo T (2000) In vivo veritas:Bcl-2 and bcl-X(L) mediate tumor cell resistance to chemotherapy. Drug Resist Update 3: 149–154

    Article  CAS  Google Scholar 

  • Fumoleau P, Bennouna J, Raymond E, Armand T-P, Hocini A, Blanchot G, Delgado FM, Marty M (2000) Phase I clinical and pharmacokinetic trial of vinflunine (L0070) a novel fluorinated Vinca alkaloid in patients (pts) with advanced solid malignancies: Preliminary results. Proceedings of the 11th NCI-EORTC-AACR Symposium on New Drugs in Cancer Therapy 576: 158

    Google Scholar 

  • Germann UA (1996) P-glycoprotein-A mediator of multidrug resistance in tumour cells. Eur J Cancer 32A: 927–944

    Article  CAS  PubMed  Google Scholar 

  • Haldar S, Jena N, Croce CM (1995) Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92: 4507–4511

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Haldar S, Basu A, Croce CM (1997) Bcl2 is the guardian of microtubule integrity. Cancer Res 57: 229–233

    CAS  PubMed  Google Scholar 

  • Hill BT, Fiebig HH, Waud WR, Poupon M-F, Colpaert F, Kruczynski A (1999) Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts. Eur J Cancer 35: 512–520

    Article  CAS  PubMed  Google Scholar 

  • Hockenbery D, Nunez G, Milliman C (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334–336

    Article  CAS  PubMed  Google Scholar 

  • Jänicke RU, Spengart ML, Wati MR, Porter AG (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273: 9357–9360

    Article  PubMed  Google Scholar 

  • Kaufmann SC, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976–3985

    CAS  PubMed  Google Scholar 

  • Kruczynski A, Colpaert F, Tarayre J-P, Mouillard P, Fahy J, Hill BT (1998a) Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid. Cancer Chemother Pharmacol 41: 437–447

    Article  CAS  PubMed  Google Scholar 

  • Kruczynski A, Barret J-M, Etiévant C, Colpaert F, Fahy J, Hill BT (1998b) Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid. Biochem Pharmacol 55: 635–648

    Article  CAS  PubMed  Google Scholar 

  • Lobert S, Ingram JW, Hill BT, Correia JJ (1998) A comparison of thermodynamic parameters for vinorelbine- and vinflunine- induced tubulin self-association by sedimentation velocity. Mol Pharmacol 53: 908–915

    CAS  PubMed  Google Scholar 

  • Lowe SC, Bodis S, McClatchey A, Remington L, Ruley HE, Fischer DE, Housman DE, Jacks T (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266: 807–810

    Article  CAS  PubMed  Google Scholar 

  • Miller DK (1997) The role of the caspase family of cysteine proteases in apoptosis. Semin Immunol 9: 35–49

    Article  CAS  PubMed  Google Scholar 

  • Mooberry SL, Busquets L, Tien G (1997) Induction of apoptosis by cryptophycin 1, a new antimicrotubule agent. Int J Cancer 73: 440–448

    Article  CAS  PubMed  Google Scholar 

  • Osborn MT, Chambers TC (1996) Role of the stress-activated/c-Jun NH2-terminal protein pathway in the cellular response to doxorubicin and other chemotherapeutic drugs. J Biol Chem 271: 30950–30955

    Article  CAS  PubMed  Google Scholar 

  • Rupnow BA, Murtha AD, Alarcon RM, Giaccia AJ, Knox SJ (1998) Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy. Cancer Res 58: 1779–1784

    CAS  PubMed  Google Scholar 

  • Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, Longo DL (1998) Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol 18: 3509–3517

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stoetzer OJ, Pogrebniak A, Scholz M, Pelka-Fleischer R, Gullis E, Darsow M, Nussler V, Wilmanns W (1999) Drug-induced apoptosis in chronic lymphocytic leukemia. Leukemia 13: 1873–1880

    Article  CAS  PubMed  Google Scholar 

  • Stone AA, Chambers TC (2000) Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signalling pathways in human KB-3 carcinoma cells. Exp Cell Res 254: 110–119

    Article  CAS  PubMed  Google Scholar 

  • Toh HC, Sun L, Koh CH, Aw SE (1998) Vinorelbine induces apoptosis and caspase-3 (CPP32) expression in leukemia and lymphoma cells: a comparison with vincristine. Leukemia and Lymphoma 31: 195–208

    Article  CAS  PubMed  Google Scholar 

  • Torres K, Horwitz SB (1998) Mechanisms of taxol-induced cell death are concentration dependent. Cancer Res 58: 3620–3626

    CAS  PubMed  Google Scholar 

  • Wang CY, Gutteridge DC, Mayo MW, Baldwin ASJ (1999a) NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 19: 5923–5929

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang LG, Liu XM, Kreis W, Budman DR (1999b) The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol 44: 355–361

    Article  CAS  PubMed  Google Scholar 

  • Wang T-H, Wang H-S, Ichijo H, Giannakakou P, Foster JS, Fojo T, Wimalasena J (1998) Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both ras and apoptosis signal-regulating kinase pathways. J Biol Chem 273: 4928–4936

    Article  CAS  PubMed  Google Scholar 

  • Wyllie AH (1997) Apoptosis: an overview. Br Med Bull 53: 451–465

    Article  CAS  PubMed  Google Scholar 

  • Zhang H, Cowan-Jacob SW, Simonen M, Greenhalf W, Heim J, Meyhack B (2000) Structural basis of BFL-1 for its interaction with BAX and its anti-apoptotic action in mammalian and yeast cells. J Biol Chem 275: 11092–11099

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Nathalie Cabrol, Jacqueline Astruc, Eric Chazottes, Valérie Cassabois and Stéphane Gras for their skilled technical assistance.

Author information

Authors and Affiliations

  1. Division of Experimental Cancer Research, Centre de Recherche Pierre Fabre, 17 avenue Jean Moulin, Castres, 81106, Cedex 06, France

    A Kruczynski, C Etiévant, D Perrin, N Chansard & B T Hill

  2. Division of Medicinal Chemistry V, Centre de Recherche Pierre Fabre, 17 avenue Jean Moulin, Castres, 81106, Cedex 06, France

    A Duflos

Authors
  1. A Kruczynski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Etiévant
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Perrin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N Chansard
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Duflos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B T Hill
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Kruczynski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kruczynski, A., Etiévant, C., Perrin, D. et al. Characterization of cell death induced by vinflunine, the most recent Vinca alkaloid in clinical development. Br J Cancer 86, 143–150 (2002). https://doi.org/10.1038/sj.bjc.6600025

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bjc.6600025

Keywords

This article is cited by

Search

Advanced search

Quick links